View in EDS

A modular and controllable T cell therapy platform for acute myeloid leukemia.

Saved in:
Bibliographic Details
Title: A modular and controllable T cell therapy platform for acute myeloid leukemia.
Authors: Benmebarek MR; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany., Cadilha BL; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany., Herrmann M; Department of Medicine III, Klinikum der Universität München, LMU, Munich, Germany., Lesch S; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany., Schmitt S; Department of Medicine III, Klinikum der Universität München, LMU, Munich, Germany., Stoiber S; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany., Darwich A; Mucosal Immunology and Microbiota Lab, Humanitas Clinical and Research Center, Milan, Italy., Augsberger C; Department of Medicine III, Klinikum der Universität München, LMU, Munich, Germany., Brauchle B; Department of Medicine III, Klinikum der Universität München, LMU, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany., Rohrbacher L; Department of Medicine III, Klinikum der Universität München, LMU, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany., Oner A; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany., Seifert M; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany., Schwerdtfeger M; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany., Gottschlich A; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany., Rataj F; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany., Fenn NC; Department of Medicine III, Klinikum der Universität München, LMU, Munich, Germany., Klein C; Roche Innovation Center Zurich, Schlieren, Switzerland., Subklewe M; Department of Medicine III, Klinikum der Universität München, LMU, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany.; German Center for Translational Cancer Research (DKTK), Partner Site Munich, Munich, Germany., Endres S; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany.; German Center for Translational Cancer Research (DKTK), Partner Site Munich, Munich, Germany.; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany., Hopfner KP; Gene Center, LMU, Munich, Germany., Kobold S; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany. Sebastian.kobold@med.uni-muenchen.de.; German Center for Translational Cancer Research (DKTK), Partner Site Munich, Munich, Germany. Sebastian.kobold@med.uni-muenchen.de.; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany. Sebastian.kobold@med.uni-muenchen.de.
Source: Leukemia [Leukemia] 2021 Aug; Vol. 35 (8), pp. 2243-2257. Date of Electronic Publication: 2021 Jan 07.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33414484
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A modular and controllable T cell therapy platform for acute myeloid leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Benmebarek+MR%22">Benmebarek MR</searchLink>; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Cadilha+BL%22">Cadilha BL</searchLink>; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Herrmann+M%22">Herrmann M</searchLink>; Department of Medicine III, Klinikum der Universität München, LMU, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Lesch+S%22">Lesch S</searchLink>; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Schmitt+S%22">Schmitt S</searchLink>; Department of Medicine III, Klinikum der Universität München, LMU, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Stoiber+S%22">Stoiber S</searchLink>; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Darwich+A%22">Darwich A</searchLink>; Mucosal Immunology and Microbiota Lab, Humanitas Clinical and Research Center, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Augsberger+C%22">Augsberger C</searchLink>; Department of Medicine III, Klinikum der Universität München, LMU, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Brauchle+B%22">Brauchle B</searchLink>; Department of Medicine III, Klinikum der Universität München, LMU, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Rohrbacher+L%22">Rohrbacher L</searchLink>; Department of Medicine III, Klinikum der Universität München, LMU, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Oner+A%22">Oner A</searchLink>; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Seifert+M%22">Seifert M</searchLink>; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Schwerdtfeger+M%22">Schwerdtfeger M</searchLink>; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Gottschlich+A%22">Gottschlich A</searchLink>; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Rataj+F%22">Rataj F</searchLink>; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Fenn+NC%22">Fenn NC</searchLink>; Department of Medicine III, Klinikum der Universität München, LMU, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Klein+C%22">Klein C</searchLink>; Roche Innovation Center Zurich, Schlieren, Switzerland.<br /><searchLink fieldCode="AU" term="%22Subklewe+M%22">Subklewe M</searchLink>; Department of Medicine III, Klinikum der Universität München, LMU, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany.; German Center for Translational Cancer Research (DKTK), Partner Site Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Endres+S%22">Endres S</searchLink>; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany.; German Center for Translational Cancer Research (DKTK), Partner Site Munich, Munich, Germany.; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany.<br /><searchLink fieldCode="AU" term="%22Hopfner+KP%22">Hopfner KP</searchLink>; Gene Center, LMU, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Kobold+S%22">Kobold S</searchLink>; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany. Sebastian.kobold@med.uni-muenchen.de.; German Center for Translational Cancer Research (DKTK), Partner Site Munich, Munich, Germany. Sebastian.kobold@med.uni-muenchen.de.; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany. Sebastian.kobold@med.uni-muenchen.de.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228704895%22">Leukemia</searchLink> [Leukemia] 2021 Aug; Vol. 35 (8), pp. 2243-2257. <i>Date of Electronic Publication: </i>2021 Jan 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%2C+Specialist+Journals%22">Nature Publishing Group, Specialist Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8704895 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5551 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208876924%22">08876924 </searchLink><i>NLM ISO Abbreviation: </i>Leukemia <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33414484
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41375-020-01109-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2243
    Titles:
      – TitleFull: A modular and controllable T cell therapy platform for acute myeloid leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Benmebarek MR
      – PersonEntity:
          Name:
            NameFull: Cadilha BL
      – PersonEntity:
          Name:
            NameFull: Herrmann M
      – PersonEntity:
          Name:
            NameFull: Lesch S
      – PersonEntity:
          Name:
            NameFull: Schmitt S
      – PersonEntity:
          Name:
            NameFull: Stoiber S
      – PersonEntity:
          Name:
            NameFull: Darwich A
      – PersonEntity:
          Name:
            NameFull: Augsberger C
      – PersonEntity:
          Name:
            NameFull: Brauchle B
      – PersonEntity:
          Name:
            NameFull: Rohrbacher L
      – PersonEntity:
          Name:
            NameFull: Oner A
      – PersonEntity:
          Name:
            NameFull: Seifert M
      – PersonEntity:
          Name:
            NameFull: Schwerdtfeger M
      – PersonEntity:
          Name:
            NameFull: Gottschlich A
      – PersonEntity:
          Name:
            NameFull: Rataj F
      – PersonEntity:
          Name:
            NameFull: Fenn NC
      – PersonEntity:
          Name:
            NameFull: Klein C
      – PersonEntity:
          Name:
            NameFull: Subklewe M
      – PersonEntity:
          Name:
            NameFull: Endres S
      – PersonEntity:
          Name:
            NameFull: Hopfner KP
      – PersonEntity:
          Name:
            NameFull: Kobold S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2021 Aug
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1476-5551
          Numbering:
            – Type: volume
              Value: 35
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Leukemia
              Type: main
ResultId 1